Drug discovery Is changing. Drug development must change too.
In this New Scientist CoLab podcast, experts from global life sciences leader Cytiva explain the hidden, high-stakes science of purification that is required to close the gap betwe...
Search fresh public links, source activity, and ready-to-use post angles for Drug Discovery..
Fresh curated links around Drug discovery. are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
In this New Scientist CoLab podcast, experts from global life sciences leader Cytiva explain the hidden, high-stakes science of purification that is required to close the gap betwe...
The Bengaluru-based company builds models that generate molecules and predict how they will behave, and has licensed its lead candidate to a US developer.
Researchers have developed a visible-light-driven method that could help chemists build more complex drug-like molecules in fewer steps. A blue light commonly used in aquariums and...
The researchers identified Nys34 as a leading candidate after it demonstrated three-to-eightfold lower toxicity than amphotericin B in multiple human cell lines and reduced fungal...
The collaboration is specifically focused on applying Receptor.AI's computational platform to Sethera's proprietary polymacrocyclic peptide chemistry, encoded screening data, and r...
Elix and the University of Vienna will partner to bridge the gap between advanced structural biology and artificial intelligence. By integrating AI’s predictive power with experime...
by Wenyu Zhang, Yizheng Wang, Yixiao Zhai, Pinglu Zhang, Yijie Ding, Quan Zou The rapid emergence of drug-resistant pathogens poses a critical threat to global health. With tradit...
Ampyrone—an NSAID-related compound—has emerged as a promising way to enhance melanin production in human skin, according to a preclinical study led by Weill Cornell Medicine and Na...
Artificial intelligence is often framed as the technology that suddenly changed drug discovery. But that narrative misses an important truth: computational, or in silico, drug disc...
Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...
Through its entry into Lilly Gateway Labs, Rznomics officials say they plan to accelerate candidate discovery and development across its target gene database bank comprising over 2...
Anthropic has just published the results of a protein design campaign. Fifteen targets, a written brief and an instruction to design small proteins that latch onto them. The model...
The KTP provides access to academic expertise while embedding that capability within Centrix’s business. This project represents an opportunity to apply advanced data science techn...
A scalable platform to discover molecular glue degraders has been developed, identifying the first metabolically activated glue. The approach expands protein degradation targets, e...
Insider Brief A team of Singapore-based researchers reports that a hybrid quantum-classical method could offer a new route to studying drug candidates using today’s Noisy Intermedi...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufac...
In a result that is already sending ripples through the fields of neuroscience and drug design, chemists at the University of California, Davis have performed something akin to a m...
During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR;...
by Brian R. Ferolito, Andrea R. V. R. Horimoto, Kai Gravel-Pucillo, Daniel J. Golden, Hesam Dashti, Claudia Giambartolomei, Danielle Rasooly, Rachael Matty, Liam Gaziano, Yakov Tse...
AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...
Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted development.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.